EUA
Quest SARS-CoV-2 rRT-PCR
FDA Emergency Use Authorization · Quest Diagnostics Nichols Institute · Mar 10, 2023
Key facts
| Product | Quest SARS-CoV-2 rRT-PCR |
|---|---|
| Company | Quest Diagnostics Nichols Institute |
| Product type | Real-time RT-PCR, Home Collection, Pooling, Multiple Targets, Screening (Anterior Nasal) |
| Date | Mar 10, 2023 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 10–99 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: